Anti-NY ESO-1 mTCR Peripheral Blood Lymphocytes
Clinical trial NCT02774291 · TERMINATED
Trial details
- NCT number
- NCT02774291
- Sponsor
- Albert Einstein College of Medicine
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-20
- Primary completion
- 2020-07-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.